Relevance of So 2024 VarSome-vs-CanVIG-UK agreement on conflicting BRCA1 missense variants to "Interpret BRCA1/BRCA2 germline variants"
- Use case
- Interpret BRCA1/BRCA2 germline variants
- Assessed by
- So 2024 VarSome-vs-CanVIG-UK agreement on conflicting BRCA1 missense variants
- Relevance
- Proxy evidence
- Endpoint
- Tool-vs-tool concordance between VarSome and the CanVIG-UK BRCA1/BRCA2 gene-specific guidance, each consolidated to a three-category scheme, on 450 BRCA1 missense variants with conflicting ClinVar interpretations
Measures agreement between two interpretation tools on a conflicting-classification subset; this is tool-vs-tool agreement on disputed BRCA1 missense variants, not accuracy against independent ground truth.
1 reviewed evaluation
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
15 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|---|---|
Citation locations1 values
| Reinterpretation of Conflicting ClinVar BRCA1 Missense Variants Using VarSome and CanVIG-UK Gene-Specific Guidance uc-clinical-20261005-source-so-2024: Results, Section 3.3, Comparison of Classification Results Between Varsome and CanVIG-UK Version: 2024 published article (Diagnostics (Basel)); CanVIG-UK gene-specific guidance v1.17 / consensus specification v2.17 applied | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Constraints1 values
| Reinterpretation of Conflicting ClinVar BRCA1 Missense Variants Using VarSome and CanVIG-UK Gene-Specific Guidance uc-clinical-20261005-source-so-2024: Results, Section 3.3, Comparison of Classification Results Between Varsome and CanVIG-UK Version: 2024 published article (Diagnostics (Basel)); CanVIG-UK gene-specific guidance v1.17 / consensus specification v2.17 applied | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Endpoint Tool-vs-tool concordance between VarSome and the CanVIG-UK BRCA1/BRCA2 gene-specific guidance, each consolidated to a three-category scheme, on 450 BRCA1 missense variants with conflicting ClinVar interpretations Context-only references | Reinterpretation of Conflicting ClinVar BRCA1 Missense Variants Using VarSome and CanVIG-UK Gene-Specific Guidance uc-clinical-20261005-source-so-2024: Results, Section 3.3, Comparison of Classification Results Between Varsome and CanVIG-UK Version: 2024 published article (Diagnostics (Basel)); CanVIG-UK gene-specific guidance v1.17 / consensus specification v2.17 applied | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Claimed field links:assessed_by:uc-clinical-20261005-so-2024-protocol Context-only references | Reinterpretation of Conflicting ClinVar BRCA1 Missense Variants Using VarSome and CanVIG-UK Gene-Specific Guidance uc-clinical-20261005-source-so-2024: Results, Section 3.3, Comparison of Classification Results Between Varsome and CanVIG-UK Version: 2024 published article (Diagnostics (Basel)); CanVIG-UK gene-specific guidance v1.17 / consensus specification v2.17 applied | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Limitations3 values
| Reinterpretation of Conflicting ClinVar BRCA1 Missense Variants Using VarSome and CanVIG-UK Gene-Specific Guidance uc-clinical-20261005-source-so-2024: Results, Section 3.3, Comparison of Classification Results Between Varsome and CanVIG-UK Version: 2024 published article (Diagnostics (Basel)); CanVIG-UK gene-specific guidance v1.17 / consensus specification v2.17 applied | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Pinned records6 values
| Reinterpretation of Conflicting ClinVar BRCA1 Missense Variants Using VarSome and CanVIG-UK Gene-Specific Guidance uc-clinical-20261005-source-so-2024: Results, Section 3.3, Comparison of Classification Results Between Varsome and CanVIG-UK Version: 2024 published article (Diagnostics (Basel)); CanVIG-UK gene-specific guidance v1.17 / consensus specification v2.17 applied | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Rationale Measures agreement between two interpretation tools on a conflicting-classification subset; this is tool-vs-tool agreement on disputed BRCA1 missense variants, not accuracy against independent ground truth. Context-only references | Reinterpretation of Conflicting ClinVar BRCA1 Missense Variants Using VarSome and CanVIG-UK Gene-Specific Guidance uc-clinical-20261005-source-so-2024: Results, Section 3.3, Comparison of Classification Results Between Varsome and CanVIG-UK Version: 2024 published article (Diagnostics (Basel)); CanVIG-UK gene-specific guidance v1.17 / consensus specification v2.17 applied | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Reason Add independently checked primary-source protocol evidence from the additive 2026-10-05 BRCA1/BRCA2 evidence intake (issue #343); scope the endpoint to tool-vs-tool agreement on conflicting BRCA1 missense variants, not accuracy. Context-only references | Reinterpretation of Conflicting ClinVar BRCA1 Missense Variants Using VarSome and CanVIG-UK Gene-Specific Guidance uc-clinical-20261005-source-so-2024: Results, Section 3.3, Comparison of Classification Results Between Varsome and CanVIG-UK Version: 2024 published article (Diagnostics (Basel)); CanVIG-UK gene-specific guidance v1.17 / consensus specification v2.17 applied | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Relevance proxy Context-only references | Reinterpretation of Conflicting ClinVar BRCA1 Missense Variants Using VarSome and CanVIG-UK Gene-Specific Guidance uc-clinical-20261005-source-so-2024: Results, Section 3.3, Comparison of Classification Results Between Varsome and CanVIG-UK Version: 2024 published article (Diagnostics (Basel)); CanVIG-UK gene-specific guidance v1.17 / consensus specification v2.17 applied | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Revision 1 Context-only references | Reinterpretation of Conflicting ClinVar BRCA1 Missense Variants Using VarSome and CanVIG-UK Gene-Specific Guidance uc-clinical-20261005-source-so-2024: Results, Section 3.3, Comparison of Classification Results Between Varsome and CanVIG-UK Version: 2024 published article (Diagnostics (Basel)); CanVIG-UK gene-specific guidance v1.17 / consensus specification v2.17 applied | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Sources and history
Release 2026-11-21-c8bea25e5abb · Record review: source checked
1 source record and release history
- Reinterpretation of Conflicting ClinVar BRCA1 Missense Variants Using VarSome and CanVIG-UK Gene-Specific Guidance · Original source · 2024 published article (Diagnostics (Basel)); CanVIG-UK gene-specific guidance v1.17 / consensus specification v2.17 applied
Technical metadata and extraction receipts
Stable ID: use-case-mapping-20261005-343-1d76c37513fa
- field
- links:assessed_by:uc-clinical-20261005-so-2024-protocol
- value
- uc-clinical-20261005-so-2024-protocol
- relevance
- proxy
- endpoint
- Tool-vs-tool concordance between VarSome and the CanVIG-UK BRCA1/BRCA2 gene-specific guidance, each consolidated to a three-category scheme, on 450 BRCA1 missense variants with conflicting ClinVar interpretations
- rationale
- Measures agreement between two interpretation tools on a conflicting-classification subset; this is tool-vs-tool agreement on disputed BRCA1 missense variants, not accuracy against independent ground truth.
- constraints
- 450 BRCA1 missense variants with conflicting ClinVar interpretations as of 20 December 2022.
- limitations
- Tool-vs-tool agreement on conflicting-classification variants, not accuracy against independent ground truth.; The source's ground-truth-anchored comparator covers only 17/450 (3.8%) of variants and is not used in this mapping.; No reviewer time or serious-error adjudication reported.
- revision
- 1
- reason
- Add independently checked primary-source protocol evidence from the additive 2026-10-05 BRCA1/BRCA2 evidence intake (issue #343); scope the endpoint to tool-vs-tool agreement on conflicting BRCA1 missense variants, not accuracy.
- citation locators
- source id: uc-clinical-20261005-source-so-2024; locator: Results, Section 3.3, Comparison of Classification Results Between Varsome and CanVIG-UK
- source locator
- uc-clinical-20261005-source-so-2024: Results, Section 3.3, Comparison of Classification Results Between Varsome and CanVIG-UK
- review
- method: automated-source-review; reviewer: claude-sonnet; reviewer note: Claude Sonnet clinical coverage worker (research-evidence intake), root integration review; reviewed at: 2026-10-05T17:39:47.679Z; note: Source-backed literature curation with independent automated transcription and scope checks against the additive 2026-10-05 BRCA1/BRCA2 evidence intake (issue #343). No new model execution, independent experimental replication, qualified human scientific review or clinical validation.
- reviewed evaluations
- uc-clinical-20261005-so-2024-evaluation
- pins
- record id: uc-clinical-20261005-so-2024-concordance-rate; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 354577d98401406c7ac887dc7812efa8cd61091c34de5b692bcfa7b262d7cd2f; record id: uc-clinical-20261005-so-2024-concordant-count; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 4236f2636ed5da1350b89dc7b821fb4a5c65865ebd427ea771cded9e2c715ea9; record id: uc-clinical-20261005-so-2024-evaluation; fields: status; links; attributes.origin; attributes.comparison; sha256: d518be73e4b3ea5c85152bdca51dbea80fa27dca49aaba974c6b0dbe45289991; record id: uc-clinical-20261005-so-2024-protocol; fields: status; name; description; facets; source_ids; links; attributes; sha256: c443b9cd6fc25f2939772a45878da344928e91a8d301e199dcaf616e8534f487; record id: uc-clinical-20261005-source-so-2024; fields: status; attributes.artifact_sha256; sha256: 99e23ac5df4df3e92d1f76f7aa908b8e3fd695aa63d68652f34ac94cd069a410; record id: use-case-brca1-brca2-germline-interpretation; fields: status; name; description; facets; attributes.question; attributes.decision; attributes.inputs; attributes.output; attributes.exclusions; attributes.setting; attributes.clinical_scope; attributes.intended_users; sha256: 9681ae92e727dde7a801aec8d4884ec28b009d134a52d806a266f7d3b64bd5bd